159 related articles for article (PubMed ID: 30012207)
1. Determination of the binding affinities of Neisseria meningitidis serogroup W capsule polymerase with two nucleotide sugar substrates.
Sharyan A; Gonzalez C; Ukaegbu O; Powell K; McCarthy PC
BMC Res Notes; 2018 Jul; 11(1):482. PubMed ID: 30012207
[TBL] [Abstract][Full Text] [Related]
2. Investigation of bioluminescence-based assays for determination of kinetic parameters for the bifunctional Neisseria meningitidis serogroup W capsule polymerase.
Sheikhi Moghaddam L; Adegbite A; McCarthy PC
BMC Res Notes; 2021 Nov; 14(1):417. PubMed ID: 34794506
[TBL] [Abstract][Full Text] [Related]
3. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development.
Fiebig T; Berti F; Freiberger F; Pinto V; Claus H; Romano MR; Proietti D; Brogioni B; Stummeyer K; Berger M; Vogel U; Costantino P; Gerardy-Schahn R
Glycobiology; 2014 Feb; 24(2):150-8. PubMed ID: 24259400
[TBL] [Abstract][Full Text] [Related]
5. The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.
Litschko C; Romano MR; Pinto V; Claus H; Vogel U; Berti F; Gerardy-Schahn R; Fiebig T
J Biol Chem; 2015 Oct; 290(40):24355-66. PubMed ID: 26286750
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase.
Muindi KM; McCarthy PC; Wang T; Vionnet J; Battistel M; Jankowska E; Vann WF
Glycobiology; 2014 Feb; 24(2):139-49. PubMed ID: 24134880
[TBL] [Abstract][Full Text] [Related]
7. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis.
Swartley JS; Liu LJ; Miller YK; Martin LE; Edupuganti S; Stephens DS
J Bacteriol; 1998 Mar; 180(6):1533-9. PubMed ID: 9515923
[TBL] [Abstract][Full Text] [Related]
9. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
10. Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production.
Fiebig T; Litschko C; Freiberger F; Bethe A; Berger M; Gerardy-Schahn R
J Biol Chem; 2018 Jan; 293(3):953-962. PubMed ID: 29187601
[No Abstract] [Full Text] [Related]
11. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
12. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
13. Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.
McCarthy PC; Saksena R; Peterson DC; Lee CH; An Y; Cipollo JF; Vann WF
Glycoconj J; 2013 Dec; 30(9):857-70. PubMed ID: 23949787
[TBL] [Abstract][Full Text] [Related]
14. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
15. Capture of Pb
Ghimire S; McCarthy PC
Biomolecules; 2018 May; 8(2):. PubMed ID: 29734757
[TBL] [Abstract][Full Text] [Related]
16. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
Cui XL; Wu X; Li MQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
[No Abstract] [Full Text] [Related]
17. Characterizing non-hydrolyzing Neisseria meningitidis serogroup A UDP-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase using UDP-N-acetylmannosamine (UDP-ManNAc) and derivatives.
Zhang L; Muthana MM; Yu H; McArthur JB; Qu J; Chen X
Carbohydr Res; 2016 Jan; 419():18-28. PubMed ID: 26598987
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations.
Baker CJ
J Adolesc Health; 2016 Aug; 59(2 Suppl):S29-37. PubMed ID: 27449147
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.
Rojas E; Hoyos J; Oldfield NJ; Lee P; Flint M; Jones CH; Ala'Aldeen DA; Jansen KU; Anderson AS
PLoS One; 2015; 10(7):e0132140. PubMed ID: 26147212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
